Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences has excelled in the last Research Excellence Framework (REF) results.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences has excelled in the last Research Excellence Framework (REF) results.

The REF assesses the quality and impact of research submitted by universities across all disciplines, with the latest results showing top-ranking for Oxford’s clinical medicine.

NDORMS submitted to the REF’s Unit of Assessment 1 - Clinical Medicine - alongside other academic departments, and contributed significantly to the excellent results of UoA1 at Oxford; the sub-panel welcomed the strong return in orthopaedic sciences, as well as the outstanding reach and significance of the impacts from research in musculoskeletal and ageing.

Professor Andrew Carr, Head of NDORMS, said: "NDORMS has made a significant contribution to the nationally top ranked submission from the University of Oxford. It is particularly gratifying to have been specifically mentioned by the assessment panel for both the quality of our publications and the impact of our research. This is a testament to the world class multidisciplinary researchers working in the department."

The results for UoA1 show Clinical Medicine at Oxford ranked top on overall REF research profile (GPA rank) using all quality scores. Overall, we were also top ranked with maximum 4* score, where 53% of overall submissions were judged to be world-leading for originality, significance and rigour, and 92% of our overall quality profile was rated as ‘world leading’ or ‘internationally excellent’. On addition, 82% of our research impacts were scored 4* - outstanding in terms of reach and significance - and 18% scored 3*.

You can see an example of how research at NDORMS significantly impacts people’s lives in this short video on fighting arthritis.

Read more on the University’s page and see the University's REF 2014 results table.

Similar stories

Doctor Ghada Alsaleh awarded a Versus Arthritis Career Development Fellowship

Postdoctoral Researcher Ghada Alsaleh has been awarded a research grant by Versus Arthritis which she will use to develop a new therapy for osteoarthritis.

Study finds marked differences in the use of ankle replacements across six countries

A new study published in Foot and Ankle International reviews the use of ankle replacements across 6 countries to predict why there is a variance in their use, and to determine how far current demands are being met.

NDORMS wins government funding to develop AI for bone health

A state-of-the-art method that uses artificial intelligence to check bone health and reduce fracture risk has been successful in the latest round of the Artificial Intelligence in Health and Care Award.

COVID-19 vaccine safety monitoring should account for age, gender, and database differences

The largest, most extensive global network study on background rates for adverse events of special interest identifies important age, sex and database differences that should inform future safety surveillance efforts.

Professor Keith Willett recognised in Queen’s Birthday Honours

Professor of Orthopaedic Trauma Surgery at NDORMS, Keith Willett becomes a Knight Bachelor for services to the NHS.

Professor Dani Prieto-Alhambra elected to ISPE Board of Directors

Dani Prieto-Alhambra, Professor of Pharmaco- and Device Epidemiology at NDORMS, has been elected as the Academic representative for Europe and Africa on the International Society of Pharmaco-Epidemiology Board of Directors.